Correlation between markers and disease burden expressed as CAG
Use of 3D Printing Techniques to Fabricate Implantable
Temporal dynamics of serum NfL levels in individuals developing
Neurofilament Light Protein as a Potential Blood Biomarker for
Neurofilament light protein in blood as a potential biomarker of
Duration of prodrome and of disease
NfL levels before and after conversion to clinically established
Plasma neurofilament light chain predicts cerebellar atrophy and
Plasma Neurofilament Light Indicative of Neuronal Damage in
Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1
Tau and neurofilament light‐chain as fluid biomarkers in
Neurofilament light protein in blood as a potential biomarker of
Neurofilaments as biomarkers in neurological disorders
Dr Lauren Byrne on Twitter: CSF mHTT rises slowly and linearly